Rosenberg Sa
-
- Lymphoma Diagnosis and Treatment 17
- Genetic factors in colorectal cancer 4
- Oncology top 5%
- Vascular Tumors and Angiosarcomas 5
- Cancer Immunotherapy and Biomarkers 3
- Immunology top 10%
- Immunotherapy and Immune Responses 10
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
-
- Lung Cancer Treatments and Mutations 10
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Kaplan HsDorfman RfElizabeth StevensMona El‐GamilYutaka KawakamiNelsen TsRonald A. CastellinoR Warnke
- Journals
- Oncology nursing forum (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (2 papers)PubMed (37 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Rosenberg Sa
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Pathology and Forensic Medicine 604
- Oncology 680
- Immunology 368
- Genetics 180
- Pulmonary and Respiratory Medicine 443
Countries citing papers authored by Rosenberg Sa
This map shows the geographic impact of Rosenberg Sa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosenberg Sa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosenberg Sa more than expected).
Fields of papers citing papers by Rosenberg Sa
This network shows the impact of papers produced by Rosenberg Sa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosenberg Sa. The network helps show where Rosenberg Sa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rosenberg Sa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The development of new cancer therapies based on the molecular identification of cancer regression antigens. | 2006 | 5 |
| 2 | Hodgkin's disease: no stage beyond cure. | 1986 | 5 |
| 3 | The concept, evolution and preliminary results of the current Stanford clinical trials for Hodgkin's disease. | 1985 | 21 |
| 4 | Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2. | 1985 | 22 |
| 5 | Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas. | 1984 | 42 |
| 6 | Adoptive immunotherapy of cancer: accomplishments and prospects. | 1984 | 84 |
| 7 | Phase I study of human leukocyte interferon in patients with advanced cancer. | 1983 | 6 |
| 8 | Intellectually handicapped mothers: problems and prospects. | 1982 | 20 |
| 9 | Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy. | 1981 | 2 |
| 10 | Inhibition of pokeweed mitogen-induced immunoglobulin production in humans by gold compounds. | 1979 | 19 |
| 11 | Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. | 1977 | 130 |
| 12 | Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience. | 1977 | 29 |
| 13 | Combined modality therapy in malignant lymphomas. | 1977 | 39 |
| 14 | Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. | 1977 | 177 |
| 15 | Pathology of malignant lymphomas in the liver: application in staging. | 1976 | 31 |
| 16 | Surgical treatment of malignant melanoma. | 1976 | 15 |
| 17 | Clinical trials in the non-Hodgkin's lymphomata at Stanford University experimental design and preliminary results. | 1975 | 19 |
| 18 | International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72. | 1973 | 5 |
| 19 | Problems with the leukocyte migration inhibition technique in the study of human tumor immunity. | 1973 | 5 |
| 20 | [Clinical classification of Hodgkin's disease. Its importance and the influence of general signs]. | 1966 | 1 |
About Rosenberg Sa
Rosenberg Sa is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Pulmonary and Respiratory Medicine and Genetics, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Immunotherapy and Immune Responses (10 papers), Lung Cancer Treatments and Mutations (10 papers), Vascular Tumors and Angiosarcomas (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (604 citations), Oncology (680 citations), Immunology (368 citations), Genetics (180 citations) and Pulmonary and Respiratory Medicine (443 citations). Rosenberg Sa has collaborated with scholars based in United States and France. Frequent co-authors include Kaplan Hs, Dorfman Rf, Elizabeth Stevens, Mona El‐Gamil, Yutaka Kawakami, Nelsen Ts, Ronald A. Castellino, R Warnke, Eli Glatstein and NR Dunnick. Their work appears in journals such as Oncology nursing forum, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.